AlphaFold predicted structure
IRF8 · Q02556

Mean pLDDT
74.7/ 100
Confident
426 residues
Confidence breakdown
- Very high(≥ 90)51%
- Confident(70–90)15%
- Low(50–70)7%
- Very low(< 50)27%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
interferon regulatory factor 8
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalimmunodeficiency 32B
B-cell chronic lymphocytic leukemia
lymphoid leukemia
immunodeficiency disease
Oral ulcer
liver disorder
leukemia
plasma cell myeloma
non-Hodgkin lymphoma
Hodgkins lymphoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Interferon regulatory factor 8
Transcription factor that specifically binds to the upstream regulatory region of type I interferon (IFN) and IFN-inducible MHC class I genes (the interferon consensus sequence (ICS)) (PubMed:25122610). Can both act as a transcriptional activator or repressor (By similarity). Plays a negative regulatory role in cells of the immune system (By similarity). Involved in CD8(+) dendritic cell differentiation by forming a complex with the BATF-JUNB heterodimer in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF8 and activation of genes (By similarity). Required for the development of plasmacytoid dendritic cells (pDCs), which produce most of the type I IFN in response to viral infection (By similarity). Positively regulates macroautophagy in dendritic cells (PubMed:29434592). Acts as a transcriptional repressor of osteoclast differentiation factors such as NFATC1 and EEIG1 (By similarity)
IRF8 · Q02556

Mean pLDDT
74.7/ 100
Confident
426 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0